Genome Compiler Asks USPTO to Reexamine DNA2.0 Patent in Ongoing Legal Row | GenomeWeb

Genome Compiler Corporation has asked the US Patent and Trademark Office to reexamine the legal document at the heart of an ongoing lawsuit filed against the company by competing gene synthesis firm DNA2.0 just over a year ago.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.